Genomics Market

Genomics Market by Product & Service (System & Software, Consumables, Services), Technology (Sequencing, PCR), Application (Drug Discovery & Development, Diagnostic, Agriculture), End User (Hospital & Clinics, Research Centers) & Region - Global Forecasts to 2025

Report Code: BT 2209 Feb, 2021, by marketsandmarkets.com

The global genomics market in terms of revenue was estimated to be worth $22.7 billion in 2020 and is poised to reach $54.4 billion by 2025, growing at a CAGR of 19.0% from 2020 to 2025. Growing government investments to support genomics projects and the growing prevalence of various disorders such as cancer and genetic disorders will propel market growth. Moreover, advancements of NGS in cancer research coupled with the entry of various new players and start-ups in the genomics market are driving the growth of the market. Furthermore, increasing the affordability of genomics technology and improving patient outcomes are expected to boost market growth.

Genomics Market Size

To know about the assumptions considered for the study, Request for Free Sample Report

Genomics Market Dynamics

Drivers: Favorable government initiatives for research on genomics

Governments of various nations are supporting and investing in public and private research institutions. Their focus is to emphasise efforts to resolve the complexity of the human genome, define the genomic basis of human health and disease, and ensure that genomics is used safely to enhance patient care and benefit society through government, public, and private institutions. In recent years, governments in various countries have made significant investments in the field of genomics for the development of new technologies. Listed below are some examples of developments on this front:

  • In January 2020, the Department of Biotechnology (DBT) initiated the “Genome India Project” (GIP). The project aims to collect 10,000 genetic samples from citizens across India to build a reference genome. Some of the areas of focus of this project are precision health, rare genetic disorders, mutation spectrum of genetic and complex diseases in the Indian population, genetic epidemiology of multifactorial lifestyle diseases, and translational research.
  • In October 2019, The National Center for Advancing Translational Sciences (NCATS) funded USD 7 million to HudsonAlpha Institute for Biotechnology in Huntsville, Alabama for the research purpose to investigate the application of cutting-edge DNA sequencing technologies that could potentially enhance diagnosis and treatment of many common and rare diseases.
  • In September 2019, a whole-genome sequencing project of USD 224 million was created, forming a partnership of pharmaceutical firms and health experts, which will examine and sequence the genetic code of 500,000 volunteers at the UK Biobank, based in Stockport, UK. The project aims to improve health through genetic research and improve the prevention, diagnosis, and treatment of a wide range of serious and life-threatening illnesses, including cancer, heart diseases, diabetes, arthritis, and dementia.
  • In February 2019, the Minister of Science and Sport (Canada) announced funding of USD 22.7 million in addition to funding of USD 33.4 million by provincial governments to support 36 research projects through Genome Canada. The projects include various sectors such as health, agriculture, natural resources, and the environment.

Moreover, favourable regulations from government bodies, a robust number of pipeline projects, and emerging application areas such as aquaculture are opening a new door for market growth.

Opportunities: Adoption of genomics in specialized/personalized medicine

The growing requirement for personalised medicine is also driving the progress of the genomic market. Different people react differently to a particular treatment or disease, and this is the primary reason behind the ballooning popularity of personalised medicine. This approach guarantees better care outcomes. Moreover, it is expected that advancements in the field of gene therapy have the potential to replace traditional drugs and surgeries by enabling doctors to treat a disorder by inserting a gene into a patient’s cell.

Various pharmaceutical companies are increasingly investing in personalised medicine research to develop precision medicine that caters to the specific treatment requirements of patients.

  • In 2020, Chigene and MGI signed a cooperation agreement to enable breakthroughs in precision diagnosis using whole-genome sequencing. Under the terms of this agreement, the two companies will leverage their combined advantages in medical testing based on MGI’s gene sequencing platform, DNBSEQ-T7, and Chigene’s big data analysis & storage system to lead the whole-genome sequencing project.
  • In 2019, Thermo Fisher Scientific, Inc. (US) introduced the Oncomine Precision Assay, an innovative pan-cancer panel, for its Genexus platform to advance precision medicine in clinical settings.
  • In 2018, GlaxoSmithKline plc (UK) entered into a four-year collaboration with 23andMe (US) to use human genetics to guide drug development. It also invested USD 300 million in 23andMe as a part of the collaboration.

Several new products and services have emerged as a result of the trend toward individualised medications and lower sequencing costs due to the launch of NGS technology. With new competitors entering the market, the market is becoming increasingly competitive, and companies are investing in new product launches to increase their revenue and expand their consumer base by gaining a competitive edge over their rivals.

  • In June 2021, QIAGEN, a Netherlands-based provider of sample and assay technologies for molecular diagnostics, applied testing, academic, and pharmaceutical research, announced the release of the QIAprep&CRISPR Kit and CRISPR Q-Primer Solutions, which enabled researchers to analyze edited genetic material with unprecedented speed and efficiency to determine how their interventions have changed the function of the DNA sequence in question.

Challenges: Shortage of trained professionals

Factors such as the high cost of genomic equipment and the lack of technical know-how about genomics are likely to hinder the market. In certain cases, technological advancements have enabled the instruments in use to present an analysis; however, the interpretation is still dependent on the reader. Due to the complexities involved and the need for in-depth knowledge in the field of genomics, it is necessary to hire trained professionals to analyse and interpret the results of genomic sequencing data. However, owing to the shortage of trained professionals, a number of end-users face significant challenges in analysing genomic data.

By product segment, the consumables segment dominated the market in 2019.

On the basis of product and service, the genomics market is segmented into consumables, systems and software, and services. In 2019, consumables accounted for the largest share of the genomics market. Consumables are widely utilised in genomic systems, and their use will continue to rise with the growing number of genetic tests performed around the globe. The high-volume demand and usage of consumables and the development of various new products in recent years have all contributed to the growth of the segment.

By technology, the sequencing technology segment dominated the market in 2019.

On the basis of technology, the genomics market is segmented into sequencing technologies, PCR, nucleic acid extraction and purification, microarrays, and other technologies. In 2019, the sequencing segment accounted for the largest share of the market. The growth of this segment is driven by its ultra high throughput, scalability, and high speed, which enable researchers to perform a wide variety of applications, including animal breeding, agriculture, and human genomics.

By application, drug discovery and development segment contributed for the largest share of the market in 2019.

On the basis of application, the market is segmented into drug discovery and development, diagnostics, agriculture and animal research, and other applications. Drug discovery and development accounted for the largest application segment share in the genomics market in 2019. The increasing demand for innovative and new therapies for infectious or chronic diseases and the growing focus on quickly developing new therapies are driving the growth in the market. The integration of AI in genomics is accelerating the drug discovery process, reducing turnaround time, offering opportunities, and increasing adoption in the market.

North America accounted for the largest share of the market in 2019.

In 2019, North America accounted for the largest share of the overall market, followed by Europe. This is due to increased government initiatives promoting precision medicine and assisting research institutes and pharmaceutical companies. Moreover, the presence of prominent players and the adoption of several strategies by them to provide efficient genomics solutions through collaboration, new product launches in this region are major driving factors.

The Asia Pacific region is projected to be the fastest growing region over the forecast period

The Asia Pacific region is estimated to grow at the highest CAGR in the genomics market during the forecast period, mainly due to favourable government support for genomics projects, increasing awareness about newer genomics technologies such as NGS, advancements in bioinformatics, and increasing healthcare expenditure in the region. Furthermore, increasing prevalence for the development of drugs for rare diseases, as well as key player expansions to strengthen their market in the APAC region, are driving genomic market growth.

Genomics Market by Region

The market is dominated by a few globally established players such as Illumina, Inc. (US), Thermo Fisher Scientific (US) QIAGEN N.V. (Netherlands), Agilent Technologies, Inc. (US), Bio-Rad Laboratories, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), and BGI (China).

Genomics Market Report Scope

Report Metric

Details

Market Revenue in 2020

$22.7 billion

Estimated Value by 2025

$54.4billion

Growth Rate

Poised to grow at a CAGR of 19.0%

Largest Share Segments

The consumables, The sequencing technology, Drug discovery and development

Market Report Segmentation

By Product & Service, Technology, Application, End User, and Region

Growth Drivers

  • Increasing government funding to support genomics projects

  • Growing incidence of cancer and increasing applications of next-generation sequencing in cancer research

  • Entry of new players and start-ups in the genomics market

Growth Opportunities

  • Use of genomics in specialized/personalized medicine

Geographies covered

North America, Europe, APAC, MEA, and Latin America

Genomics Market Report Segmentation

By Product & Service

  • Systems & Software
  • Consumables
  • Services

By Technology

  • Sequencing
  • PCR
  • Nucleic Acid Extraction and Purification
  • Microarray
  • Other Technologies

By Application

  • Drug Discovery and Development
  • Diagnostics
  • Agriculture and Animal Research
  • Other Applications

By End User

  • Hospitals & Clinics
  • Research Centers and Academic & Government Institutes,
  • Pharmaceutical & Biotechnology Companies
  • Other End Users

By Region

  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Rest of Asia Pacific
  • Rest of the World
    • Latin America
    • The Middle East and Africa

Recent Developments

  • In 2021, Illumina (US) collaborated with Helix OpCo (US) to improve the national surveillance infrastructure in the US so as to track the emergence and prevalence of novel strains of SARS-CoV-2 with support from the CDC. Illumina’s sequencing technology and expertise and Helix’s national COVID-19 testing footprint will significantly expand the country’s existing surveillance efforts to detect and characterize emerging variants of SARS-CoV-2.
  • In 2020, BGI (China) expanded its DNA sequencing and laboratory automation products available in Latin America by signing agreements with top distributors in Brazil, Argentina, Peru, Ecuador, Colombia, and Mexico.
  • In2020, QIAGEN (Netherlands) acquired NeuMoDx Molecular (US) to strengthen its leadership position in automated molecular testing. Medium- and high-throughput NeuMoDx automation solutions based on PCR testing technology will now be integrated into QIAGEN’s portfolio
  • In 2020, Thermo Fisher Scientific (US) launched the Oncomine Myeloid Assay GX.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 20)
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION
           1.2.1 INCLUSIONS & EXCLUSIONS
    1.3 MARKET SCOPE
           1.3.1 MARKETS COVERED
           1.3.2 YEARS CONSIDERED FOR THE STUDY
    1.4 CURRENCY
    1.5 LIMITATIONS
    1.6 STAKEHOLDERS
    1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 25)
    2.1 RESEARCH DATA
           2.1.1 SECONDARY DATA
           2.1.2 PRIMARY DATA
           2.1.3 MARKET DATA ESTIMATION AND TRIANGULATION
           2.1.4 DATA TRIANGULATION
           FIGURE 1 DATA TRIANGULATION METHODOLOGY
    2.2 MARKET ESTIMATION METHODOLOGY
           FIGURE 2 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION)
           FIGURE 3 GENOMICS MARKET SIZE (USD BILLION)
           FIGURE 4 MARKET: FINAL CAGR PROJECTIONS (2020−2025)
           FIGURE 5 MARKET: CAGR PROJECTIONS FROM THE ANALYSIS OF DEMAND-SIDE DRIVERS, OPPORTUNITIES, AND CHALLENGES
           FIGURE 6 MARKET: SEGMENTAL ASSESSMENT
    2.3 INDUSTRY INSIGHTS
    2.4 RESEARCH ASSUMPTIONS

3 EXECUTIVE SUMMARY (Page No. - 33)
           FIGURE 7 GLOBAL MARKET, BY PRODUCT & SERVICE, 2020 VS. 2025 (USD BILLION)
           FIGURE 8 MARKET SHARE, BY TECHNOLOGY, 2019
           FIGURE 9 MARKET, BY APPLICATION, 2020 VS. 2025 (USD BILLION)
           FIGURE 10 MARKET, BY END USER, 2020−2025
           FIGURE 11 GEOGRAPHICAL SNAPSHOT OF THE GLOBAL MARKET

4 PREMIUM INSIGHTS (Page No. - 37)
    4.1 GENOMICS MARKET OVERVIEW
           FIGURE 12 INCREASING GOVERNMENT FUNDING TO SUPPORT GENOMICS PROJECTS TO DRIVE MARKET GROWTH
    4.2 ASIA PACIFIC: MARKET, BY APPLICATION & COUNTRY (2019)
           FIGURE 13 DRUG DISCOVERY AND DEVELOPMENT ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC MARKET IN 2019
    4.3 GLOBAL MARKET FOR SEQUENCING, BY TYPE
           FIGURE 14 NEXT-GENERATION SEQUENCING PROJECTED TO WITNESS THE HIGHEST GROWTH IN THE FORECAST PERIOD

5 MARKET OVERVIEW (Page No. - 40)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
           FIGURE 15 GLOBAL MARKET: DRIVERS, OPPORTUNITIES, CHALLENGES, AND TRENDS
           5.2.1 DRIVERS
                    5.2.1.1 Increasing government funding to support genomics projects
                    5.2.1.2 Growing incidence of cancer and increasing applications of next-generation sequencing in cancer research
           TABLE 1 GLOBAL CANCER INCIDENCE, 2020 VS. 2040
                    5.2.1.3 Entry of new players and start-ups in the genomics market
                    5.2.1.4 Growing application areas of genomics
           5.2.2 OPPORTUNITIES
                    5.2.2.1 Use of genomics in specialized/personalized medicine
           5.2.3 CHALLENGES
                    5.2.3.1 High cost of genomic equipment
                    5.2.3.2 Dearth of trained professionals
                    5.2.3.3 Secure storage of large volumes of sequenced data
           5.2.4 TRENDS
                    5.2.4.1 Partnerships and collaborations for technological advancements in genomics
                    5.2.4.2 Impact of COVID-19 on the global market
    5.3 TECHNOLOGICAL ANALYSIS
           TABLE 2 COMPARISON OF SANGER SEQUENCING AND NGS
    5.4 VALUE CHAIN ANALYSIS
           FIGURE 16 VALUE CHAIN ANALYSIS—MAXIMUM VALUE IS ADDED DURING THE SEQUENCING AND ANALYSIS PHASE
    5.5 REGULATORY ANALYSIS
           5.5.1 NORTH AMERICA
                    5.5.1.1 US
           TABLE 3 US FDA: MEDICAL DEVICE CLASSIFICATION
           TABLE 4 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
           5.5.2 EUROPE
           FIGURE 17 EUROPE: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES (MDR)
                    5.5.2.1 Asia Pacific
                               5.5.2.1.1 China
           TABLE 5 CHINA: CLASSIFICATION OF MEDICAL DEVICES
    5.6 ECOSYSTEM ANALYSIS OF THE GLOBAL MARKET
           FIGURE 18 ECOSYSTEM ANALYSIS OF THE GLOBAL MARKET

6 GENOMICS MARKET, BY PRODUCT & SERVICE (Page No. - 57)
    6.1 INTRODUCTION
           TABLE 6 GLOBAL MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
    6.2 CONSUMABLES
           6.2.1 CONSUMABLES FORM THE LARGEST PRODUCT SEGMENT OF THE GLOBAL MARKET
           TABLE 7 GENOMICS CONSUMABLES MARKET, BY REGION, 2018–2025 (USD MILLION)
           TABLE 8 GENOMICS CONSUMABLES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
    6.3 SYSTEMS & SOFTWARE
           6.3.1 DECLINING RATES OF GENOME SEQUENCING TO INCREASE THE DEMAND FOR GENOMICS SYSTEMS & SOFTWARE
           TABLE 9 GENOMICS SYSTEMS & SOFTWARE MARKET, BY REGION, 2018–2025 (USD MILLION)
           TABLE 10 GENOMICS SYSTEMS & SOFTWARE MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
    6.4 SERVICES
           6.4.1 HIGH COST OF GENOMIC INSTRUMENTS AND THE POSSIBILITY OF INSTRUMENT OBSOLESCENCE HAVE DRIVEN END USERS TO OUTSOURCE THEIR SEQUENCING NEEDS
           TABLE 11 GENOMICS SERVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
           TABLE 12 GENOMICS SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)

7 GENOMICS MARKET, BY TECHNOLOGY (Page No. - 65)
    7.1 INTRODUCTION
           TABLE 13 GLOBAL MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
    7.2 SEQUENCING
           7.2.1 INCREASING APPLICATIONS OF SEQUENCING IN HUMAN GENOMICS TO DRIVE MARKET GROWTH
           TABLE 14 MARKET FOR SEQUENCING, BY REGION, 2018–2025 (USD MILLION)
           TABLE 15 GLOBAL MARKET FOR SEQUENCING, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 16 MARKET FOR SEQUENCING, BY TYPE, 2018–2025 (USD MILLION)
    7.3 PCR
           7.3.1 PCR ALLOWS RESEARCHERS TO PRODUCE MILLIONS OF COPIES OF A SPECIFIC DNA SEQUENCE WITHIN HOURS
           TABLE 17 MARKET FOR PCR, BY REGION, 2018–2025 (USD MILLION)
           TABLE 18 GLOBAL MARKET FOR PCR, BY COUNTRY, 2018–2025 (USD MILLION)
    7.4 NUCLEIC ACID EXTRACTION AND PURIFICATION
           7.4.1 ADVANCES IN NUCLEIC ACID EXTRACTION AND PURIFICATION TECHNOLOGIES ARE EXPECTED TO SUPPORT THE GROWTH OF THIS MARKET
           TABLE 19 MARKET FOR NUCLEIC ACID EXTRACTION AND PURIFICATION, BY REGION, 2018–2025 (USD MILLION)
           TABLE 20 GLOBAL MARKET FOR NUCLEIC ACID EXTRACTION AND PURIFICATION, BY COUNTRY, 2018–2025 (USD MILLION)
    7.5 MICROARRAYS
           7.5.1 HIGH ADOPTION OF NGS MAY LIMIT THE GROWTH OF MICROARRAY TECHNOLOGIES IN THIS MARKET TO A CERTAIN EXTENT
           TABLE 21 MARKET FOR MICROARRAYS, BY REGION, 2018–2025 (USD MILLION)
           TABLE 22 GLOBAL MARKET FOR MICROARRAYS, BY COUNTRY, 2018–2025 (USD MILLION)
    7.6 OTHER TECHNOLOGIES
           TABLE 23 MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2018–2025 (USD MILLION)
           TABLE 24 MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2018–2025 (USD MILLION)

8 GENOMICS MARKET, BY APPLICATION (Page No. - 75)
    8.1 INTRODUCTION
           TABLE 25 MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
    8.2 DRUG DISCOVERY AND DEVELOPMENT
           8.2.1 DRUG DISCOVERY AND DEVELOPMENT FORMS THE LARGEST APPLICATION SEGMENT OF THE MARKET
           TABLE 26 GENOMICS MARKET FOR DRUG DISCOVERY AND DEVELOPMENT APPLICATIONS, BY REGION, 2018–2025 (USD MILLION)
           TABLE 27 MARKET FOR DRUG DISCOVERY AND DEVELOPMENT APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
    8.3 DIAGNOSTICS
           8.3.1 GROWING APPLICATIONS OF GENOMICS IN THE DIAGNOSTICS FIELD TO PROPEL MARKET GROWTH
           TABLE 28 GRANTS, BY CANCER TYPE (AS OF OCTOBER 2020)
           TABLE 29 MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2018–2025 (USD MILLION)
           TABLE 30 GLOBAL MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 31 MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION)
    8.4 AGRICULTURE AND ANIMAL RESEARCH
           8.4.1 GENOMICS HELPS IN IMPROVING THE PRODUCTIVITY OF CROPS AND LIVESTOCK—A KEY FACTOR DRIVING MARKET GROWTH
           TABLE 32 MARKET FOR AGRICULTURE AND ANIMAL RESEARCH APPLICATIONS, BY REGION, 2018–2025 (USD MILLION)
           TABLE 33 GENOMICS MARKET FOR AGRICULTURE AND ANIMAL RESEARCH APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
    8.5 OTHER APPLICATIONS
           TABLE 34 MARKET FOR OTHER APPLICATIONS, BY REGION, 2018–2025 (USD MILLION)
           TABLE 35 MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION)

9 GENOMICS MARKET, BY END USER (Page No. - 85)
    9.1 INTRODUCTION
           TABLE 36 MARKET, BY END USER, 2018–2025 (USD MILLION)
    9.2 HOSPITALS & CLINICS
           9.2.1 INCREASING DEMAND FOR PHARMACOGENOMICS TO DRIVE THE ACCEPTANCE OF NGS IN HOSPITALS
           TABLE 37 MARKET FOR HOSPITALS & CLINICS, BY REGION, 2018–2025 (USD MILLION)
           TABLE 38 GENOMICS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2018–2025 (USD MILLION)
    9.3 RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES
           9.3.1 INCREASE IN RESEARCH INTENSITY TO DRIVE THE USAGE OF GENOMICS PRODUCTS AMONG ACADEMIC & GOVERNMENT INSTITUTES
           TABLE 39 MARKET FOR RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES, BY REGION, 2018–2025 (USD MILLION)
           TABLE 40 GLOBAL MARKET FOR RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES, BY COUNTRY, 2018–2025 (USD MILLION)
    9.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
           9.4.1 GROWING IMPORTANCE OF BIOMARKERS TO DRIVE THE USE OF GENOMICS PRODUCTS & SERVICES AMONG PHARMA & BIOTECH COMPANIES
           TABLE 41 GLOBAL MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018–2025 (USD MILLION)
           TABLE 42 MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018–2025 (USD MILLION)
    9.5 OTHER END USERS
           TABLE 43 MARKET FOR OTHER END USERS, BY REGION, 2018–2025 (USD MILLION)
           TABLE 44 MARKET FOR OTHER END USERS, BY COUNTRY, 2018–2025 (USD MILLION)

10 GENOMICS MARKET, BY REGION (Page No. - 93)
     10.1 INTRODUCTION
           FIGURE 19 NORTH AMERICA WILL CONTINUE TO DOMINATE THE GLOBAL MARKET DURING THE FORECAST PERIOD
           TABLE 45 GLOBAL MARKET, BY REGION, 2018–2025 (USD MILLION)
     10.2 NORTH AMERICA
           FIGURE 20 NORTH AMERICA: GENOMICS MARKET SNAPSHOT
           TABLE 46 NORTH AMERICA: MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 47 NORTH AMERICA: MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
           TABLE 48 NORTH AMERICA: MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
           TABLE 49 NORTH AMERICA: MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
           TABLE 50 NORTH AMERICA: MARKET, BY END USER, 2018–2025 (USD MILLION)
             10.2.1 US
                        10.2.1.1 US dominates the North American genomics market
           TABLE 51 US: GENOMICS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
           TABLE 52 US: MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
           TABLE 53 US: MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
           TABLE 54 US: MARKET, BY END USER, 2018–2025 (USD MILLION)
             10.2.2 CANADA
                        10.2.2.1 Increasing research in the field of genomics to drive market growth
           TABLE 55 CANADA: GENOMICS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
           TABLE 56 CANADA: MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
           TABLE 57 CANADA: MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
           TABLE 58 CANADA: MARKET, BY END USER, 2018–2025 (USD MILLION)
     10.3 EUROPE
           TABLE 59 EUROPE: GENOMICS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 60 EUROPE: MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
           TABLE 61 EUROPE: MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
           TABLE 62 EUROPE: MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
           TABLE 63 EUROPE: MARKET, BY END USER, 2018–2025 (USD MILLION)
             10.3.1 UK
                        10.3.1.1 Availability of government funding and strategic collaborations with biotech firms to boost the market
           TABLE 64 UK: GENOMICS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
           TABLE 65 UK: MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
           TABLE 66 UK: MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
           TABLE 67 UK: MARKET, BY END USER, 2018–2025 (USD MILLION)
             10.3.2 GERMANY
                        10.3.2.1 Increasing awareness of NGS in the country to boost the market growth in Germany
           TABLE 68 GERMANY: GENOMICS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
           TABLE 69 GERMANY: MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
           TABLE 70 GERMANY: MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
           TABLE 71 GERMANY: MARKET, BY END USER, 2018–2025 (USD MILLION)
             10.3.3 FRANCE
                        10.3.3.1 Increasing government investments in genomics to boost the growth of the French genomics market
           TABLE 72 FRANCE: GENOMICS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
           TABLE 73 FRANCE: MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
           TABLE 74 FRANCE: MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
           TABLE 75 FRANCE: MARKET, BY END USER, 2018–2025 (USD MILLION)
             10.3.4 ROE
           TABLE 76 ROE: GENOMICS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
           TABLE 77 ROE: MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
           TABLE 78 ROE: MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
           TABLE 79 ROE: MARKET, BY END USER, 2018–2025 (USD MILLION)
     10.4 ASIA PACIFIC
           FIGURE 21 ASIA PACIFIC: GENOMICS MARKET SNAPSHOT
           TABLE 80 ASIA PACIFIC: MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 81 ASIA PACIFIC: MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
           TABLE 82 ASIA PACIFIC: MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
           TABLE 83 ASIA PACIFIC: MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
           TABLE 84 ASIA PACIFIC: MARKET, BY END USER, 2018–2025 (USD MILLION)
             10.4.1 CHINA
                        10.4.1.1 China is expected to command the largest share of the Asia Pacific market
           TABLE 85 CHINA: GENOMICS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
           TABLE 86 CHINA: MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
           TABLE 87 CHINA: MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
           TABLE 88 CHINA: MARKET, BY END USER, 2018–2025 (USD MILLION)
             10.4.2 JAPAN
                        10.4.2.1 Growing conferences and workshops on newer genomics technologies such as NGS to increase awareness and drive the market
           TABLE 89 JAPAN: GENOMICS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
           TABLE 90 JAPAN: MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
           TABLE 91 JAPAN: MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
           TABLE 92 JAPAN: MARKET, BY END USER, 2018–2025 (USD MILLION)
             10.4.3 INDIA
                        10.4.3.1 Emergence of local players & increasing adoption of genomics technologies is expected to aid the growth of the genomics market in India
           TABLE 93 INDIA: GENOMICS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
           TABLE 94 INDIA: MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
           TABLE 95 INDIA: MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
           TABLE 96 INDIA: MARKET, BY END USER, 2018–2025 (USD MILLION)
             10.4.4 REST OF ASIA PACIFIC
           TABLE 97 ROAPAC: GENOMICS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
           TABLE 98 ROAPAC: MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
           TABLE 99 ROAPAC: MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
           TABLE 100 ROAPAC: MARKET, BY END USER, 2018–2025 (USD MILLION)
     10.5 REST OF THE WORLD
           TABLE 101 ROW: GENOMICS MARKET, BY REGION, 2018–2025 (USD MILLION)
           TABLE 102 ROW: MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
           TABLE 103 ROW: MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
           TABLE 104 ROW: MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
           TABLE 105 ROW: MARKET, BY END USER, 2018–2025 (USD MILLION)
             10.5.1 LATIN AMERICA
                        10.5.1.1 Expansions of key players in Latin American regions to boost the market
           TABLE 106 LATIN AMERICA: GENOMICS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
           TABLE 107 LATIN AMERICA: MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
           TABLE 108 LATIN AMERICA: GENOMICS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
           TABLE 109 LATIN AMERICA: MARKET, BY END USER, 2018–2025 (USD MILLION)
             10.5.2 MIDDLE EAST & AFRICA
                        10.5.2.1 Increasing adoption of genetic testing in the Middle East and rising HIV & cancer incidence in Africa are driving market growth
           TABLE 110 MIDDLE EAST & AFRICA: GENOMICS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
           TABLE 111 MIDDLE EAST & AFRICA: MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
           TABLE 112 MIDDLE EAST & AFRICA: MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
           TABLE 113 MIDDLE EAST & AFRICA: GENOMICS MARKET, BY END USER, 2018–2025 (USD MILLION)

11 COMPETITIVE LANDSCAPE (Page No. - 130)
     11.1 INTRODUCTION
     11.2 MARKET SHARE ANALYSIS
           FIGURE 22 GENOMICS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2019
     11.3 MARKET EVALUATION FRAMEWORK
           TABLE 114 MARKET EVALUATION FRAMEWORK: PRODUCT & SERVICE LAUNCHES —THE MAJOR STRATEGY ADOPTED BY PLAYERS
     11.4 COMPETITIVE BENCHMARKING
             11.4.1 ANALYSIS OF THE PRODUCT PORTFOLIO OF MAJOR PLAYERS IN THE GENOMICS MARKET
     11.5 COMPETITIVE SCENARIO
             11.5.1 KEY PRODUCT LAUNCHES
             11.5.2 KEY COLLABORATIONS, PARTNERSHIPS, AND AGREEMENTS
             11.5.3 KEY EXPANSIONS
             11.5.4 KEY ACQUISITIONS
     11.6 COMPANY EVALUATION MATRIX
             11.6.1 GLOBAL GENOMICS MARKET: COMPANY EVALUATION MATRIX (OVERALL MARKET) (2019)
                        11.6.1.1 Stars
                        11.6.1.2 Emerging leaders
                        11.6.1.3 Pervasive players
                        11.6.1.4 Participants
           FIGURE 23 GLOBAL GENOMICS MARKET: COMPANY EVALUATION MATRIX, 2019
             11.6.2 COMPETITIVE LEADERSHIP MAPPING (START-UPS) (2019)
                        11.6.2.1 Progressive companies
                        11.6.2.2 Starting blocks
                        11.6.2.3 Dynamic companies
                        11.6.2.4 Responsive companies
           FIGURE 24 COMPETITIVE LEADERSHIP MAPPING: GENOMICS MARKET

12 COMPANY PROFILES (Page No. - 139)
(Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)* 
     12.1 MAJOR PLAYERS
             12.1.1 ILLUMINA, INC.
           FIGURE 25 ILLUMINA, INC.: COMPANY SNAPSHOT (2019)
             12.1.2 THERMO FISHER SCIENTIFIC, INC.
           FIGURE 26 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2019)
             12.1.3 QIAGEN N.V.
           FIGURE 27 QIAGEN N.V.: COMPANY SNAPSHOT (2019)
             12.1.4 AGILENT TECHNOLOGIES
           FIGURE 28 AGILENT TECHNOLOGIES: COMPANY SNAPSHOT (2020)
             12.1.5 F. HOFFMANN-LA ROCHE, LTD.
           FIGURE 29 F. HOFFMANN-LA ROCHE, LTD.: COMPANY SNAPSHOT (2019)
             12.1.6 BIO-RAD LABORATORIES, INC.
           FIGURE 30 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2019)
             12.1.7 EUROFINS SCIENTIFIC
           FIGURE 31 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2019)
             12.1.8 OXFORD NANOPORE TECHNOLOGIES
             12.1.9 BGI
             12.1.10 DANAHER CORPORATION
           FIGURE 32 DANAHER CORPORATION: COMPANY SNAPSHOT (2019)
             12.1.11 EPPENDORF AG
           FIGURE 33 EPPENDORF AG: COMPANY SNAPSHOT (2019)
             12.1.12 MERCK KGAA
           FIGURE 34 MERCK KGAA: COMPANY SNAPSHOT (2019)
             12.1.13 NEW ENGLAND BIOLABS
             12.1.14 PROMEGA CORPORATION
             12.1.15 CREATIVE BIOGENE
             12.1.16 START-UP/SME PLAYERS
                        12.1.16.1 Novogene Co., Ltd.
                        12.1.16.2 Helix OpCo, LLC
                        12.1.16.3 23andMe, Inc.
                        12.1.16.4 Personal Genome Diagnostics Inc. (PGDx)
                        12.1.16.5 Personalis, Inc.
*Details on Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View might not be captured in case of unlisted companies. 

13 APPENDIX (Page No. - 185)
     13.1 DISCUSSION GUIDE
     13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     13.3 AVAILABLE CUSTOMIZATIONS
     13.4 RELATED REPORTS
     13.5 AUTHOR DETAILS

This market research study involved the extensive use of secondary sources, directories, and databases to identify and collect information useful for this technical, market-oriented, and financial study of the global genomics market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify critical qualitative and quantitative information and to assess market prospects. The size of the genomics market was estimated through various secondary research approaches and triangulated with inputs from primary research to arrive at the final market size.

Secondary Research

The secondary sources referred to for this research study included publications from government sources such as the International Chromosome and Genome Society (ICGS), International Mammalian Genome Society (IMGS), International Agency for Research on Cancer (IARC), National Human Genome Research Institute (NHGRI), International Service for Acquisition of Agri-Biotech Applications (ISAAA), Genome Canada, European Society of Human Genetics (ESHG), Genomics England, Centre for Cellular & Molecular Biology (India) (CCMB), Japan Agency for Medical Research and Development, Kinghorn Centre for Clinical Genomics (Australia) (KCCG), King Abdulaziz City for Science and Technology (KACST), and São Paulo Research Foundation (FAPESP).

Secondary sources also include corporate and regulatory filings (such as annual reports, SEC filings, investor presentations, and financial statements); business magazines and research journals; press releases; and trade, business, and professional associations, among others. Secondary data was collected and analyzed to arrive at the overall size of the global genomics market, which was validated through primary research.

Primary Research

Extensive primary research was conducted after acquiring basic knowledge about the global genomics market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (such as personnel from hospitals & clinics, research centers, government & academic institutes, and pharmaceutical & biopharmaceutical companies) and supply side (such as C-level and D-level executives, product managers, marketing and sales managers of key manufacturers, distributors, and channel partners, among others) across four major regions, namely, North America, Europe, the Asia Pacific, and the Rest of the World. Approximately 80% and 20% of primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

Genomics Market Size

To know about the assumptions considered for the study, download the pdf brochure

Data Triangulation

After arriving at the overall size of the genomics market through the methodology mentioned above, this market was split into several segments and subsegments. Market breakdown procedures were employed, wherever applicable, to arrive at the exact market value for the key segments and subsegments. The extrapolated market data was triangulated by studying various macroindicators and regional trends from both demand- and supply-side participants.

Report Objectives

  • To define, describe, and forecast the genomics market on the basis of product & service, application, technology, end user, and region
  • To provide detailed information regarding the factors influencing the market growth (such as drivers, opportunities, challenges, and trends)
  • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall genomics market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To profile the key players in the global genomics market and comprehensively analyze their core competencies and market rankings
  • To forecast the size of the market segments in North America, Europe, Asia Pacific (APAC), and the Rest of the World (RoW)
  • To track and analyze competitive developments such as product launches, product approvals, product enhancements, expansions, acquisitions, partnerships, collaborations, and agreements in the genomics market

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the report:

Geographical Analysis

  • Further breakdown of the European genomics market into RoE countries
  • Further breakdown of the Asia Pacific genomics market into RoAPAC countries
  • Further breakdown of the Rest of the World (RoW) genomics market into Mexico, Argentina, and the RoW countries

Company Information

  • Detailed analysis and profiling of additional market players (Up to 5)
Report Code
BT 2209
Published ON
Feb, 2021
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Genomics Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2023 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback